Research by Michael Klein, M.D., and others has identified rare genetic variants that may be involved in developing age-related macular degeneration, and could be used to develop new therapies.

Research by Michael Klein, M.D., and others has identified rare genetic variants that may be involved in developing age-related macular degeneration, and could be used to develop new therapies.

Research by Michael Klein, M.D., and others has identified rare genetic variants that may be involved in developing age-related macular degeneration, and could be used to develop new therapies.

In an announcement from the American Association for Cancer Research, Lisa Coussens, Ph.D., applauds the recently-announced National Cancer Institute’s National Cancer Plan but notes the plan will require national funding. She says: “However, if we are to succeed in achieving these goals — including realizing the promise of new approaches to preventing and treating cancer — Congress must prioritize investments in cancer research, primarily through NCI.”

Article on a study led by Jeanette Johnstone, Ph.D., involving micronutrients for treatment of youths with ADHD. Initial findings were published in May of 2022, including on OHSU News.

In light of new mass shootings across the country, the Association of State and Territorial Health Officials highlights Oregon’s collaboration with OHSU researchers to prevent firearm injuries and death by taking a public health approach, starting by collecting and tracking data.

Before April 3, when Oregon Health Authority ended its mask requirement in health care spaces, OHSU announces its new guidelines, strongly recommending that masks continue to be worn in health care settings. Masks are still required in certain areas.

In a Q&A with Pharmacy Times, Alison M. Palumbo, PharmD, discusses innovating tools and means of assessing patient-reported outcome measures at Hematology/Oncology Pharmacy Association Annual Conference. She says, "Quality of life is a clinical outcome. Patients care about living longer and living better. Quality of life helps address the living better portion. So if we can better collect information on quality of life, then we can hopefully improve patient outcomes."

A MIM Software press release announces its software is in the majority of health care facilities designated as Radiopharmaceutical Therapy Comprehensive Centers of Excellence by the SNMMI, including OHSU. Erik Mittra, M.D., Ph.D., says, "Dosimetry for radiopharmaceutical therapies is an increasingly important tool that will allow us to be more proactive with complex patient treatment decisions. We are excited to start providing this service to patients."

Research by Michael Klein, M.D., and others has identified rare genetic variants that may be involved in developing age-related macular degeneration, and could be used to develop new therapies.